Premium
Psoriasis Area and Severity Index vs. pharmacokinetics: can monitoring 4‐week postinjection ustekinumab concentrations in patients with suboptimal response be clinically relevant?
Author(s) -
Puig L.
Publication year - 2020
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.18709
Subject(s) - ustekinumab , medicine , psoriasis , psoriasis area and severity index , pharmacokinetics , dermatologic agents , oncology , dermatology , disease , antibiotics , biology , microbiology and biotechnology , infliximab
Linked Article: Van den Berghe et al . Br J Dermatol 2020; 182 :390–397.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom